JCR Pharmaceuticals. (JCRRF) Q4 2024 Earnings

30OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.05
0
0.06
0.11

Details

Expected EPS
0.09545004
Actual EPS
-0.04967298
Surprise EPS
-0.15
Surprise Percent
+152.04%

Description

JCR Pharmaceuticals. (JCRRF) has reported earnings of -0.04967298 per share for Q4 2024.

0 Comments

Share your thoughts